Los Angeles, CA, United States of America

Guo Cheng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guo Cheng: Innovator in Targeting Pathogenic Blood Vessels

Introduction

Guo Cheng is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical science, particularly in the development of compounds and methods for targeting pathogenic blood vessels. His innovative work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Guo Cheng holds 1 patent for his invention titled "Compounds and methods for targeting pathogenic blood vessels." This patent discloses compounds and compositions, including pharmaceutical compositions and kits that incorporate these compounds. The methods described in the patent focus on modulating PLXDC1 (TEM7) and/or PLXDC2, as well as targeting pathogenic blood vessels. Furthermore, the patent outlines methods for treating diseases, disorders, or conditions mediated by PEDF receptors or angiogenesis.

Career Highlights

Throughout his career, Guo Cheng has worked with esteemed institutions, including the University of California and Atengen, Inc. His experience in these organizations has allowed him to collaborate with other professionals in the field and further his research.

Collaborations

Guo Cheng has collaborated with notable individuals such as Hui Sun and Pu Sun. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Guo Cheng is a distinguished inventor whose work in targeting pathogenic blood vessels showcases his commitment to advancing medical science. His innovative approaches and collaborations have the potential to lead to significant breakthroughs in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…